Publication | Open Access
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement
37
Citations
13
References
2021
Year
Clinical trial identifier ToetsingOnline: NL68539.056.18 Nederlands Trials Register NL8000.
| Year | Citations | |
|---|---|---|
Page 1
Page 1